Enterprise Value
458.3M
Cash
17.63M
Avg Qtr Burn
-2.64M
Short % of Float
7.22%
Insider Ownership
5.19%
Institutional Own.
81.32%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Avance® Nerve Graft Details Nerve discontinuities | BLA Submission |